|
1
|
Yadav H, Thompson BT and Gajic O: Fifty
years of research in ARDS. Is acute respiratory distress syndrome a
preventable disease? Am J Respir Crit Care Med. 195:725–736.
2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Yang X, Li J, Ma Y, Dong X, Qu J, Liang F
and Liu J: Curcumin-mediated enhancement of lung barrier function
in rats with high-altitude-associated acute lung injury via
inhibition of inflammatory response. Respir Res.
25(354)2024.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zhang L, Li H, Li D and Dai Q: Unraveling
the synergy of inflammation and apoptosis in sepsis-induced acute
lung injury: Insights and therapeutic perspectives (review). Mol
Med Rep. 33(31)2026.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ding ZL, Ma YC, Liu CM, Lu X, Wang RR,
Tang MM, Hua DX, Zheng L, Zhao H and Fu L: 1-Nitropyrene induces
acute lung injury via SYVN1/Caspase-11-mediated apoptosis and
pyroptosis in pulmonary epithelial cells. Front Pharmacol.
17(1723593)2026.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Wu J, Ye J, Kong W, Zhang S and Zheng Y:
Programmed cell death pathways in hearing loss: A review of
apoptosis, autophagy and programmed necrosis. Cell Prolif.
53(e12915)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Long ME, Mallampalli RK and Horowitz JC:
Pathogenesis of pneumonia and acute lung injury. Clin Sci (Lond).
136:747–769. 2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Guo H, Guan J, Wu X, Wei Y, Zhao J, Zhou
Y, Li F and Pang HB: Peptide-guided delivery improves the
therapeutic efficacy and safety of glucocorticoid drugs for
treating acute lung injury. Mol Ther. 31:875–889. 2023.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yang S, Song Y, Wang Q, Liu Y, Wu Z, Duan
X, Zhang Y, Bi X, Geng Y, Chen S and Zhu C: Daphnetin ameliorates
acute lung injury in mice with severe acute pancreatitis by
inhibiting the JAK2-STAT3 pathway. Sci Rep.
11(11491)2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chen IC, Wang SC, Chen YT, Tseng HH, Liu
PL, Lin TC, Wu HE, Chen YR, Tseng YH, Hsu JH, et al: Corylin
ameliorates LPS-induced acute lung injury via suppressing the MAPKs
and IL-6/STAT3 signaling pathways. Pharmaceuticals (Basel).
14(1046)2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhu L, Wu H, Ma Z, Dong D, Yang Z and Tian
J: Astaxanthin ameliorates lipopolysaccharide-induced acute lung
injury via inhibition of inflammatory reactions and modulation of
the SOCS3/JAK2/STAT3 signaling pathways in mice. Food Funct.
13:11638–11651. 2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wang K, Wu M, Xu J, Wu C, Zhang B, Wang G
and Ma D: Effects of dexmedetomidine on perioperative stress,
inflammation, and immune function: Systematic review and
meta-analysis. Br J Anaesth. 123:777–794. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhang Q, Huang Y, Gong C, Tang Y, Xiong J,
Wang D and Liu X: Dexmedetomidine attenuates inflammation and organ
injury partially by upregulating Nur77 in sepsis. Immun Inflamm
Dis. 11(e883)2023.PubMed/NCBI View
Article : Google Scholar
|
|
13
|
Shi J, Yu T, Song K, Du S, He S, Hu X, Li
X, Li H, Dong S, Zhang Y, et al: Dexmedetomidine ameliorates
endotoxin-induced acute lung injury in vivo and in vitro by
preserving mitochondrial dynamic equilibrium through the
HIF-1a/HO-1 signaling pathway. Redox Biol.
41(101954)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Li F, Bai Y, Guan Z, Ji X, Zhan X, Gao Y,
Zhong W and Rao Z: Dexmedetomidine attenuates sepsis-associated
acute lung injury by regulating macrophage efferocytosis through
the ROS/ADAM10/AXL pathway. Int Immunopharmacol.
142(112832)2024.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cui H and Zhang Q: Dexmedetomidine
ameliorates lipopolysaccharide-induced acute lung injury by
inhibiting the PI3K/Akt/FoxO1 signaling pathway. J Anesth.
35:394–404. 2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Han J, Liu X and Wang L: Dexmedetomidine
protects against acute lung injury in mice via the DUSP1/MAPK/NF-κB
axis by inhibiting miR-152-3p. Pulm Pharmacol The: 102131, 2022
(Epub ahead of print).
|
|
17
|
Xin P, Xu X, Deng C, Liu S, Wang Y, Zhou
X, Ma H, Wei D and Sun S: The role of JAK/STAT signaling pathway
and its inhibitors in diseases. Int Immunopharmacol.
80(106210)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Keenan C, Albeituni S, Nichols KE and
Hines M: JAK inhibitors in cytokine storm syndromes. Adv Exp Med
Biol. 1448:583–600. 2024.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Al-Ani B, ShamsEldeen AM, Kamar SS,
Haidara MA, Al-Hashem F, Alshahrani MY, Al-Hakami AM, Kader DHA and
Maarouf A: Lipopolysaccharide induces acute lung injury and
alveolar haemorrhage in association with the cytokine storm,
coagulopathy and AT1R/JAK/STAT augmentation in a rat model that
mimics moderate and severe Covid-19 pathology. Clin Exp Pharmacol
Physiol. 49:483–491. 2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Song Z, Zhao X, Gao Y, Liu M, Hou M, Jin H
and Cui Y: Recombinant human brain natriuretic peptide ameliorates
trauma-induced acute lung injury via inhibiting JAK/STAT signaling
pathway in rats. J Trauma Acute Care Surg. 78:980–987.
2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q,
Bao Z, Lu J and Li L: Evolving cognition of the JAK-STAT signaling
pathway: Autoimmune disorders and cancer. Signal Transduct Target
Ther. 8(204)2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Xu F, Wang S, Wang Y, Hu L and Zhu L:
Inhibition of gp130 alleviates LPS-induced lung injury by
attenuating apoptosis and inflammation through JAK1/STAT3 signaling
pathway. Inflamm Res. 72:493–507. 2023.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhou JR, Liao Y, Cao LQ, Ma R, He Y, Li N,
Zhu DP, Zhao XS, Huang XJ and Sun YQ: Interleukin 6 is
significantly increased in severe pneumonia after
allo-hematopoietic stem cell transplantation and might induce lung
injury via IL-6/sIL-6R/JAK1/STAT3 pathway. J Infect Dis.
232:113–126. 2025.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lin KC, Chang TM, Sun YS, Lin YR, Tang CH
and Liu JF: CXCL8 drives MMP1 upregulation and promotes metastatic
progression in oral cancer through CXCR1/2-mediated JAK1/STAT3
activation. Int J Biol Sci. 22:2285–2301. 2026.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Shan M, Zhang S, Luo Z, Deng S, Ran L,
Zhou Q, Wan H, Ye J, Qian C, Fan X, et al: Itaconate promotes
inflammatory responses in tissue-resident alveolar macrophages and
exacerbates acute lung injury. Cell Metab. 37:1750–1765.e7.
2025.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zou X, Liu C, Huang Z, Xiang S, Li K, Yuan
Y, Hao Y and Zhou F: Inhibition of STEAP1 ameliorates inflammation
and ferroptosis of acute lung injury caused by sepsis in
LPS-induced human pulmonary microvascular endothelial cells. Mol
Biol Rep. 50:5667–5674. 2023.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tu Y, Li X, Fu Y, Chen Y, Fang H, Li Y, Gu
Y and Zhang J: Isocorydine ameliorates IL-6 expression in bone
marrow-derived macrophages and acute lung injury induced by
lipopolysaccharide. Int J Mol Sci. 24(4629)2023.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Jia J, Yuan Y, He Y, Wasti B, Duan W, Chen
Z, Li D, Sun W, Zeng Q, Ma L, et al: Inhibition of METTL3
alleviated LPS-induced alveolar epithelial cell apoptosis and acute
lung injury via restoring neprilysin expression. Life Sci.
333(122148)2023.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wang JF, Wang YP, Xie J, Zhao ZZ, Gupta S,
Guo Y, Jia SH, Parodo J, Marshall JC and Deng XM: Upregulated PD-L1
delays human neutrophil apoptosis and promotes lung injury in an
experimental mouse model of sepsis. Blood. 138:806–810.
2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kurdowska AK and Florence JM: Promoting
neutrophil apoptosis to treat acute lung injury. Am J Respir Crit
Care Med. 200:399–400. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Li X, Jamal M, Guo P, Jin Z, Zheng F, Song
X, Zhan J and Wu H: Irisin alleviates pulmonary epithelial barrier
dysfunction in sepsis-induced acute lung injury via activation of
AMPK/SIRT1 pathways. Biomed Pharmacother.
118(109363)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Liu L, Yuan Y, Zhou Y, Yao L, Li J and
Chen F: The transcription factor KLF14 attenuates LPS-induced acute
lung injury by ameliorating apoptosis of alveolar epithelial cells
in mice. Mol Immunol. 152:67–77. 2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhou X, Wang M, Sun M and Yao N: HSPB8
attenuates lipopolysaccharide-mediated acute lung injury in A549
cells by activating mitophagy. Mol Med Rep. 30(171)2024.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Li J, Chen Q, He X, Alam A, Ning J, Yi B,
Lu K and Gu J: Dexmedetomidine attenuates lung apoptosis induced by
renal ischemia-reperfusion injury through α2AR/PI3K/Akt
pathway. J Transl Med. 16(78)2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Huang L, Du B, Cui X, Zhao H, Feng Y, Xu
Z, Long J, Yuan J and You F: Nerelimomab alleviates
capsaicin-induced acute lung injury by inhibiting TNF signaling and
apoptosis. Pharmaceuticals (Basel). 17(1694)2024.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Yang J and Chen X: SIRT6 attenuates
LPS-induced inflammation and apoptosis of lung epithelial cells in
acute lung injury through ACE2/STAT3/PIM1 signaling. Immun Inflamm
Dis. 11(e809)2023.PubMed/NCBI View
Article : Google Scholar
|
|
38
|
Sims NA: The JAK1/STAT3/SOCS3 axis in bone
development, physiology, and pathology. Exp Mol Med. 52:1185–1197.
2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Traves PG, Murray B, Campigotto F, Galien
R, Meng A and Di Paolo JA: JAK selectivity and the implications for
clinical inhibition of pharmacodynamic cytokine signalling by
filgotinib, upadacitinib, tofacitinib and baricitinib. Ann Rheum
Dis. 80:865–875. 2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
RECOVERY Collaborative Group. Baricitinib
in patients admitted to hospital with COVID-19 (RECOVERY): A
randomised, controlled, open-label, platform trial and updated
meta-analysis. Lancet. 400:359–368. 2022.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Joshi K, Singh V, Chatterjee S, Khandelwal
P, Nair R, Qureshi S, Siddh S and Nunia V: Assessment of lapachol's
anti-inflammatory effectiveness in mitigating sepsis-induced acute
lung injury. Fitoterapia. 180(106298)2025.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Zhang Z, Zhu Q, Wang S and Shi C:
Epigallocatechin-3-gallate inhibits the formation of neutrophil
extracellular traps and suppresses the migration and invasion of
colon cancer cells by regulating STAT3/CXCL8 pathway. Mol Cell
Biochem. 478:887–898. 2023.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Li W, Liu Q, Xiong W, Zhong X and Tian L:
Decoding STAT3: A new frontier in understanding and treating
hyperoxic lung injury. Front Immunol. 16(1657823)2025.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Kubra KT and Barabutis N: Ceapin-A7
potentiates lipopolysaccharide-induced endothelial injury. J
Biochem Mol Toxicol. 37(e23460)2023.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Zhuo Y, Li D, Cui L, Li C, Zhang S, Zhang
Q, Zhang L, Wang X and Yang L: Treatment with
3,4-dihydroxyphenylethyl alcohol glycoside ameliorates
sepsis-induced ALI in mice by reducing inflammation and regulating
M1 polarization. Biomed Pharmacother. 116(109012)2019.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Yang S, Zhou S, Wang W, Cao L, Xue T, Xu
J, Lv K and Huang M: A novel STAT3 CCD inhibitor for suppressing
macrophage activation and lipopolysaccharide-induced acute lung
injury. Int Immunopharmacol. 143(113523)2024.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Xu S, Deng KQ, Lu C, Fu X, Zhu Q, Wan S,
Zhang L, Huang Y, Nie L, Cai H, et al: Interleukin-6 classic and
trans-signaling utilize glucose metabolism reprogramming to achieve
anti- or pro-inflammatory effects. Metabolism.
155(155832)2024.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Li R, Liang Q, Yang Q, Dai W, Xiao Y, Pan
H, Zhang Z, Liu L and Li X: Hexahydrocurcumin from Zingiberis
rhizoma attenuates lipopolysaccharide-induced acute pneumonia
through JAK1/STAT3 signaling pathway. Phytomedicine.
122(155141)2024.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Yin J, Yu Z, Hou C, Peng Y, Xiao J and
Jiang J: Protective effect of zuojin fang on lung injury induced by
sepsis through downregulating the JAK1/STAT3 signaling pathway.
Biomed Res Int. 2021(1419631)2021.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Zhang ZM, Li LZ, Li KH, An CY, Li YL, Li L
and Wu GY: The effects of dexmedetomidine administered at various
times on acute lung injury in rats. Eur Rev Med Pharmacol Sci.
25:2093–2098. 2021.PubMed/NCBI View Article : Google Scholar
|
